MRMr. Frank Rothmaier
International Healthcare & Patient Services Specialist, Founder & Director, Neurotest24 · Owner / Founder
At a glance
Core facts about the doctor and the hospital, as provided by the hospital.
1 areaSpecialties: Scientific AdvisorIntensive Care and Emergency MedicineTranslational MedicineBiochemistry and Genetic Engineering
Stem Cell TherapyCategory
US$1,650 from6 priced items
3 staffListed at this hospital
Dr. Alex Melhuish, MD is a MD · MSc by Research in Biochemistry · BSc (Hons) Genetic Engineering, Scientific Advisor at NeuroTest24 in Nicosia, Cyprus. Lists Scientific AdvisorIntensive Care and Emergency MedicineTranslational MedicineBiochemistry and Genetic Engineering. The hospital lists prices from US$1,650.
About
Dr Alex Melhuish is a medical doctor and Scientific Advisor at NeuroTest24, with an academic background in genetic engineering, biochemistry, and translational medicine.
He earned his BSc (Hons) in Genetic Engineering from Queen Mary, University of London, in 2003, followed by an MSc by Research in Biochemistry from the University of Kent in 2005, with a focus on molecular and translational medicine. He subsequently obtained his MD from I.P. Pavlov First St Petersburg State Medical University in 2012.
His professional background includes two years in translational medicine (2012–2014) and a four-year residency in intensive care and emergency medicine (2014–2018).
Dr Melhuish is affiliated with several professional medical and scientific organisations, including the Royal College of Physicians, the European Respiratory Society, and societies dedicated to translational medicine.
He earned his BSc (Hons) in Genetic Engineering from Queen Mary, University of London, in 2003, followed by an MSc by Research in Biochemistry from the University of Kent in 2005, with a focus on molecular and translational medicine. He subsequently obtained his MD from I.P. Pavlov First St Petersburg State Medical University in 2012.
His professional background includes two years in translational medicine (2012–2014) and a four-year residency in intensive care and emergency medicine (2014–2018).
Dr Melhuish is affiliated with several professional medical and scientific organisations, including the Royal College of Physicians, the European Respiratory Society, and societies dedicated to translational medicine.
Professional Experience
- ● Scientific Advisor – NeuroTest24● Translational Medicine – Two years of professional experience (2012–2014).● Intensive Care and Emergency Medicine – Four-year residency training (2014–2018).
Certifications
● Doctor of Medicine (MD) – I.P. Pavlov First St Petersburg State Medical University, 2012.
● MSc by Research in Biochemistry – University of Kent, UK, 2005.
● BSc (Hons) in Genetic Engineering – Queen Mary, University of London, UK, 2003.
● Residency Training in Intensive Care and Emergency Medicine, 2014–2018.
● MSc by Research in Biochemistry – University of Kent, UK, 2005.
● BSc (Hons) in Genetic Engineering – Queen Mary, University of London, UK, 2003.
● Residency Training in Intensive Care and Emergency Medicine, 2014–2018.
Memberships
● International Affiliate – Royal College of Physicians
● Member – European Respiratory Society
● Member – Pancyprian Medical Association
● Member – Society for Translational Medicine
● Member – European Society for Translational Medicine
● Member – European Respiratory Society
● Member – Pancyprian Medical Association
● Member – Society for Translational Medicine
● Member – European Society for Translational Medicine
Ask the doctor's team about your case
Send your reports and questions to NeuroTest24. The hospital replies through Health-Tourism.com.
Free consultation • No obligation • Direct communication with the hospital